Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Intestinal Permeability in Cirrhotic Patients
NCT02484573Unknown
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- May 2015
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of propranolol in Liver cirrhosis (LC), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Primary endpoint: Intestinal permeability at 4 weeks. Status: unknown.
02
Drugs
propranolol
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT02484573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02484573.